Yubo International Biotech Ltd
YBGJ · OTCMCIK 895464fmd_1F4ST2MD2D9CPD2S5HBNZD0PWRManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Dec 01, 2009 to Sep 30, 2026, 70 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | – | 1 | 0 | 1 | 0 | 0 |
| Cost of revenue | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Net interest income | – | – | – | – | (0) | 0 | 0 | (0) | 0 | – |
| Gross profit | – | – | – | – | 1 | 1 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Total operating expenses | – | – | – | – | 2 | 2 | 1 | 2 | 2 | 1 |
| Operating income | (0) | (0) | (0) | – | (1) | (2) | (1) | (1) | (2) | (1) |
| Interest expense | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Other non-operating income (expense) | – | – | – | – | (0) | 0 | 0 | (0) | (0) | (0) |
| Income before taxes | – | – | – | – | – | (2) | (1) | (1) | (2) | (1) |
| Income tax expense | 0 | 0 | 0 | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | – | – | (2) | (1) | (1) | (2) | (1) |
| Net income | (0) | (0) | (0) | – | (1) | (2) | (1) | (1) | (2) | (1) |
| Net income to common shareholders | – | – | – | – | – | – | – | (1) | (2) | (1) |